Healthcare Today Michigan: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Today Michigan.

Press releases published on November 4, 2026

3 hours ago

Macomb Chiropractor Uses Spinal Thermal Scan to Trace Sciatica to Its Source

Indeterminate EIN Presswire

an hour ago

Ichnos Glenmark Innovation (IGI) to Present Updated Clinical Data for ISB 2001 (ABBV-2001) in Relapsed/Refractory Multiple Myeloma at 68th ASH Annual Meeting

Indeterminate GlobeNewswire

an hour ago

Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting

Indeterminate GlobeNewswire

2 hours ago

J-Star Holding Co., Ltd. Provides Update on Capital Structure Authorization and Strategic Execution Timeline

Indeterminate GlobeNewswire

2 hours ago

ORYZON to Present Updated Positive Clinical Data for Iadademstat in Hematological Malignancies at ASH 2026

Indeterminate GlobeNewswire

2 hours ago

AI in Life Sciences Market to Worth USD 69.34 Billion by 2031, at a CAGR of 26.3% – MarketsandMarkets™

Indeterminate GlobeNewswire

2 hours ago

Translational Data from Anal Cancer Patients Show Pelareorep Drives HPV-Specific Immune Responses, Supporting its Potential Across HPV-Driven Cancers

Indeterminate GlobeNewswire

2 hours ago

Metagenomi Therapeutics to Present Preclinical Data Supporting MGX-001, a Potential One-Time Therapy for Hemophilia A, in Oral Presentation at 68th American Society of Hematology Annual Meeting

Indeterminate GlobeNewswire

2 hours ago

Applied Biologics Announces Full Enrollment of BIOxHEAL™ Phase 3 Sentinel Safety Cohort

Indeterminate GlobeNewswire

2 hours ago

Immix Biopharma’s NXC-201 NEXICART-2 Interim Clinical Trial Results Selected for Oral Presentation at ASH 2026

Indeterminate GlobeNewswire

2 hours ago

Autolus Therapeutics to Present Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2026

Indeterminate GlobeNewswire

2 hours ago

Cullinan Therapeutics Announces Presentations for CLN-049, a FLT3 T Cell Engager, and Velinotamig, a BCMA T Cell Engager, at the 68th ASH Annual Meeting

Indeterminate GlobeNewswire

2 hours ago

Tangram Announces Oral Presentation of TGM-148 Preclinical Data Highlighting Context-Dependent Mechanism of Action at the American Society of Hematology (ASH) 2026 Annual Meeting

Indeterminate GlobeNewswire

2 hours ago

Disc Medicine Announces Multiple Presentations Across Portfolio at the 68th American Society of Hematology (ASH) Annual Meeting

Indeterminate GlobeNewswire

2 hours ago

Daré Bioscience to Present at Stifel’s 2026 Healthcare Conference

Indeterminate GlobeNewswire

2 hours ago

Hemab Therapeutics to Present Clinical and Preclinical Data from Multiple Blood Coagulation Programs at the 68th ASH Annual Meeting and Exposition

Indeterminate GlobeNewswire

2 hours ago

Solu Therapeutics to Present Initial Phase 1 Results of STX-0712 and New Preclinical Data on STX-0640 in Two Oral Presentations at the 2026 ASH Annual Meeting

Indeterminate GlobeNewswire

2 hours ago

Kura Oncology and Kyowa Kirin to Present First Ziftomenib-FLT3 Inhibitor Clinical Data at ASH 2026

Indeterminate GlobeNewswire

2 hours ago

Lyell Immunopharma Announces $80 Million Private Placement to Advance Ronde-Cel Toward Planned BLA Submission

Indeterminate GlobeNewswire

2 hours ago

Lakefront Biotherapeutics Announces Poster Presentation at the 2026 American Society of Hematology Meeting

Indeterminate GlobeNewswire